ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Russell 2000 Stocks with Open Questions

BARK Cover Image

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Picking the right small caps isn’t easy, and that’s exactly why StockStory exists - to help you focus on the best opportunities. That said, here are three Russell 2000 stocks that don’t make the cut and some better choices instead.

Bark (BARK)

Market Cap: $135 million

Making a name for itself with the BarkBox, Bark (NYSE: BARK) specializes in subscription-based, personalized pet products.

Why Should You Sell BARK?

  1. Lackluster 5.2% annual revenue growth over the last five years indicates the company is losing ground to competitors
  2. Cash burn makes us question whether it can achieve sustainable long-term growth
  3. Short cash runway increases the probability of a capital raise that dilutes existing shareholders

At $0.78 per share, Bark trades at 39.8x forward EV-to-EBITDA. Check out our free in-depth research report to learn more about why BARK doesn’t pass our bar.

Select Medical (SEM)

Market Cap: $1.86 billion

With a nationwide network spanning 46 states and over 2,700 healthcare facilities, Select Medical (NYSE: SEM) operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers across the United States.

Why Does SEM Worry Us?

  1. Declining admissions over the past two years show it’s struggled to increase its sales volumes and had to rely on price increases
  2. Earnings per share fell by 9.3% annually over the last five years while its revenue was flat, showing each sale was less profitable
  3. High net-debt-to-EBITDA ratio of 6× increases the risk of forced asset sales or dilutive financing if operational performance weakens

Select Medical is trading at $14.96 per share, or 12x forward P/E. Read our free research report to see why you should think twice about including SEM in your portfolio.

Washington Trust Bancorp (WASH)

Market Cap: $641.5 million

Founded in 1800 and operating as Rhode Island's oldest community bank, Washington Trust Bancorp (NASDAQ: WASH) is a regional bank holding company offering commercial banking, mortgage lending, personal banking, and wealth management services.

Why Should You Dump WASH?

  1. 3.7% annual net interest income growth over the last five years was slower than its banking peers
  2. Net interest margin of 2.2% reflects its high servicing and capital costs
  3. Sales over the last five years were less profitable as its earnings per share fell by 7.8% annually while its revenue was flat

Washington Trust Bancorp’s stock price of $33.67 implies a valuation ratio of 1.2x forward P/B. Dive into our free research report to see why there are better opportunities than WASH.

Stocks We Like More

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.94
+2.12 (0.98%)
AAPL  260.29
-2.23 (-0.85%)
AMD  199.45
-2.62 (-1.30%)
BAC  49.81
-0.49 (-0.97%)
GOOG  300.91
-2.54 (-0.84%)
META  660.57
-7.16 (-1.07%)
MSFT  410.68
+5.48 (1.35%)
NVDA  183.34
+0.30 (0.16%)
ORCL  154.79
+2.42 (1.59%)
TSLA  405.55
-0.39 (-0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.